Endeavor Venture Fund & Venture Studio

Endeavor Venture Fund & Venture Studio is a healthcare-focused investment firm and venture studio based in Switzerland. Managed by Dr. Martin Alexander Gershon, MD, JD, MPH, the firm is dedicated to accelerating transformative innovation in the healthcare industry. With a focus on technology and medicine, Endeavor has made a significant impact through its strategic investments in 141 groundbreaking biotech and healthcare companies, including Moderna and AI and digital healthcare companies like Grail. The firm's investment portfolio encompasses a wide range of healthcare sectors, including drug discovery and development, rare diseases, AI-driven diagnostics/biomarkers, medical devices, mental health, and women’s health. Endeavor is committed to supporting women CEOs and CEOs from diverse communities, recognizing the importance of diversity in leadership. Endeavor believes that the ongoing technological advancements in the 4th Industrial Revolution will significantly accelerate the development of new drugs, devices, and services, ultimately contributing to improved health outcomes and delivering long-term benefits for global well-being. By providing financial, strategic, and operational resources, Endeavor aims to nurture exceptional entrepreneurial talent and drive disruptive innovation in the healthcare industry. The firm is poised to foster the growth of its portfolio companies, helping them evolve into the next generation of successful unicorns. With a visionary approach to leveraging technology and scientific innovation, Endeavor is dedicated to improving access and delivery of healthcare and creating positive impacts on people's lives. The firm's dedication to advancing healthcare solutions makes it a compelling prospect for potential venture capital investors seeking opportunities in the healthcare and biotech sectors.